Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia |
Washington University / Grant Challen, PhD |
'A' Award Grants |
2012 |
Missouri |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Myron Ignatius, PhD |
'A' Award Grants |
2012 |
Massachusetts |
Childhood Leukemia in Kenya Identified Through Malaria Slide Review |
Indiana University / Terry Vik |
Epidemiology Grants |
2012 |
Indiana |
Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research |
Washington University / Kimberly Johnson Ph.D. |
Epidemiology Grants |
2012 |
Missouri |
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2012 |
Utah |
V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |
Developing Immune-modulatory Strategies Against Primary and Metastatic Tumors in the Central Nervous System |
Case Western Reserve University / Alex Huang, MD, PhD |
Innovation Grants |
2012 |
Ohio |
Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL |
The Johns Hopkins University School of Medicine / Donald Small, MD, PhD |
Innovation Grants |
2012 |
Maryland |
Modeling Pediatric Leukemia in the Zebrafish to Enable Discovery of New Anti-Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2012 |
California |